NASDAQ : NIKI
Niki BioSolutions, Inc. — Key statistics
Healthcare · Biotechnology · United States
Last price 1.77 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 5.20M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 5.20M |
| Enterprise Value | 6.88M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 2.94M |
| Shares Outstanding | 2.94M |
| Shares Change (YoY) | +23.85% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 57.33% |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.07 |
| P/TBV Ratio | 0.24 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.45 |
| Quick Ratio | 0.41 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -26.71 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -17.05% |
| Return on Assets (ROA) | -10.04% |
| Return on Invested Capital (ROIC) | -10.68% |
| Return on Capital Employed (ROCE) | -22.41% |
| Weighted Average Cost of Capital (WACC) | 0.23% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.25M |
| Employee Count | 1 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | -1.00 |
| 52-Week Price Change | +21.23% |
| 50-Day Moving Average | 4.63 |
| 200-Day Moving Average | 2.78 |
| Relative Strength Index (RSI) | 21.74 |
| Average Volume (20 Days) | 14,516 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 5,751 |
| Short Previous Month | 14,602 |
| Short % of Shares Out | 0.20% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.18 |
Incomestatement
| Measure | Value |
|---|
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -2.83M |
| Pretax Income | -2.23M |
| Net Income | -2.25M |
| EBITDA | n/a |
| EBIT | -2.83M |
| Earnings Per Share (EPS) | -$2.86 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 1.83M |
| Total Debt | 3.51M |
| Net Cash | -1.67M |
| Net Cash Per Share | -$0.57 |
| Equity (Book Value) | 12.43M |
| Book Value Per Share | 26.75 |
| Working Capital | -2.48M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -2.57M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -2.57M |
| FCF Per Share | -$0.88 |
Margins
| Measure | Value |
|---|
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -23.85% |
| Shareholder Yield | -23.85% |
| Earnings Yield | -161.54% |
| FCF Yield | -49.48% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jan 23, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |